| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/12/2004 | US20040029228 Cytokine receptor |
| 02/12/2004 | US20040029225 Lipoxygenase |
| 02/12/2004 | US20040029224 Used for determination of ligands (agonists), preparation of antibodies and antisera, construction of recombinant receptor protein expression systems, development of receptor binding assay systems and screening of pharmaceutical candidates |
| 02/12/2004 | US20040029223 Two bacterial strains deficient in endogenous adenylate cyclase activity are used in a signal amplification system comprising a bacterial multi-hybrid system |
| 02/12/2004 | US20040029222 Proteins and nucleic acids encoding same |
| 02/12/2004 | US20040029221 Identification and isolation of novel DNA and the recombinant production of novel polypeptides; for detecting the presence of tumors in mammals |
| 02/12/2004 | US20040029217 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/12/2004 | US20040029216 Used to treat blood, brain, urogenital, nervous system, sexual, bone, cardiovascular, gastrointestinal, skin disorders, cancer, bacterial/viral/fungi infections |
| 02/12/2004 | US20040029215 Industrially producing RFamide (RFRP ie Arg-Phe-Amide Related Peptides) peptides in a large scale comprises subjecting a fusion protein or peptide, in which an RFamide peptide is ligated to the N-terminal of a peptide |
| 02/12/2004 | US20040029201 Identification of targets of antimicrobial compounds |
| 02/12/2004 | US20040029199 Human cervical cancer 2 protooncogene and protein encoded therein |
| 02/12/2004 | US20040029197 Novel human cancer/testis antigen and gene thereof |
| 02/12/2004 | US20040029190 Automated methods of detecting receptor activity |
| 02/12/2004 | US20040029187 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 02/12/2004 | US20040029180 Method for identifying agonists or antagonists of the G protein-coupled receptor mas-like 1 |
| 02/12/2004 | US20040029179 Higher molecular weight entities and uses therefor |
| 02/12/2004 | US20040029178 For anti-obesity/appetite enhancing drugs; prolactin inhibitors |
| 02/12/2004 | US20040029174 End selection in directed evolution |
| 02/12/2004 | US20040029173 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 02/12/2004 | US20040029167 Inducible COMT_II promoter, chimeric gene containing same and plants transformed therewith |
| 02/12/2004 | US20040029166 Solid-liquid separation by deposition onto a solid-phase carrier, via enzymatic treatment of a cell lysis solution, from a sample containing nucleated cells |
| 02/12/2004 | US20040029163 Novel tissue-specific secretory polypeptide and dna thereof |
| 02/12/2004 | US20040029162 By carrying out a specific reaction of binding (hybridization) of said analyte with a ligand specific for this analyte, and determining the binding reaction by means of at least two fluorescent labels present on the analyte |
| 02/12/2004 | US20040029160 A triplex comprising a hairpin having polypyrimidine sequence linked to a complementary polypurine; targeting single-stranded oligonucleotides and DNA using the hairpins and triplexes |
| 02/12/2004 | US20040029157 A DNA containing a nucleotide sequence encoding the amino acid sequence with partial substitution, deletion or addition and having cell cycle control activity; for controlling abnormal cell growth like cancer |
| 02/12/2004 | US20040029156 Immobilization of biomolecules on substrates by attaching them to adsorbed bridging biomolecules |
| 02/12/2004 | US20040029155 Method for identifying a biomolecule |
| 02/12/2004 | US20040029154 Comprises detecting when an expression amount of a single gene among a plurality of genes is expressed under 2 conditions, the respective expression amounts of another gene, determining a difference between the detected values |
| 02/12/2004 | US20040029152 Fluorescent analysis element with the use of metallic nanowell and process for producing the same |
| 02/12/2004 | US20040029150 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/12/2004 | US20040029147 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 02/12/2004 | US20040029145 Novel HMGA alleles and use of the same as genetic markers for growth, fatness, meat quality, and feed efficiency traits |
| 02/12/2004 | US20040029139 System for simultaneous detection of multiple binding events in the same reaction |
| 02/12/2004 | US20040029132 Nucleic acid and amino acid sequences of drug metabolizing enzymes; used in diagnosis, treatment, and prevention of autoimmune/ inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, and gastrointestinal disorders |
| 02/12/2004 | US20040029128 Analyzing methylation patterns; cell proliferation; cancer diagnosis |
| 02/12/2004 | US20040029124 Generation hybrid Dna using primers and ligase; analyzing gene expression patterns |
| 02/12/2004 | US20040029123 Diagnosis of diseases associated with the cell cycle |
| 02/12/2004 | US20040029118 Computer readable medium having recorded thereon given nucleotide sequence; use in identifying commercially important nucleic acid fragments |
| 02/12/2004 | US20040029117 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the DNA |
| 02/12/2004 | US20040029113 Cleaving single-stranded nucleic acid sequences by contacting with a oligonucleotide; restriction endonuclease recognition site; fab fragments |
| 02/12/2004 | US20040029111 Capture oligonucleotide comprising a polynucleotide with a complementary sequence; kits; useful in determining very low levels of nucleic acids |
| 02/12/2004 | US20040029110 Hepatitis B virus (HBV); releasing, isolating or concentrating the polynucleic acids; amplification; hybridization to a mutant target sequence such as pol gene region |
| 02/12/2004 | US20040029107 DNA sequence coding for bacteriophage recombinase; ligand-binding domain of steroid receptors; vectors |
| 02/12/2004 | US20040029106 Duplexed parvovirus vectors |
| 02/12/2004 | US20040029101 Combined electroporation and microinjection method for the penetration of lipid bilayer membranes |
| 02/12/2004 | US20040028812 Vapor deposition; applying alternating electric current |
| 02/12/2004 | US20040028705 Mutants of clostridium difficile toxin B and methods of use |
| 02/12/2004 | US20040028703 Genetic engineered, low molecular weight drug; therapy, vaccine; extraction of Clostridium |
| 02/12/2004 | US20040028701 E2 subunit vaccine comprising recombinant pestivirus E2 protein |
| 02/12/2004 | US20040028700 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 02/12/2004 | US20040028693 Fusion protein viricides |
| 02/12/2004 | US20040028685 EphA2 monoclonal antibodies and methods of use thereof |
| 02/12/2004 | US20040028684 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/12/2004 | US20040028669 Human gene critical to fertility |
| 02/12/2004 | US20040028663 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer |
| 02/12/2004 | US20040028654 Protamine-adenoviral vector complexes and methods of use |
| 02/12/2004 | US20040028653 Self-rearranging DNA vectors |
| 02/12/2004 | US20040028652 Composition and method for stimulating immune response to pathogen using complex adenoviral vector |
| 02/12/2004 | US20040028651 Composition and methods of using hiv vpr |
| 02/12/2004 | US20040028568 Biochemical analysis unit |
| 02/12/2004 | US20040028489 Rotatable cutting tool |
| 02/12/2004 | DE10234739A1 New interfering splice variant of human p53 protein, useful for identifying modulators of p53 function, and potential anticancer agents |
| 02/12/2004 | DE10234116A1 Preparation of recombinant single-chain Fv fragments in plants, useful for control of plant and human viral infections, comprises using an expression vector |
| 02/12/2004 | DE10233516A1 Cellular method for identifying modulators of target molecules, useful in screening for pharmaceuticals, from effects of test compounds on both cell growth and reporter expression |
| 02/12/2004 | DE10232621A1 Für ein Enzym Delta-12-Desaturase kodierende Nukleinsäuresequenz, zugehöriges Polypeptid und Verwendung von beiden For an enzyme delta-12 desaturase-encoding nucleic acid sequence associated polypeptide and use of both |
| 02/12/2004 | DE10225180A1 Protein oder Peptid (MIMPD), hierfür codierende Nukleinsäure sowie Verwendungen dieser Stoffe Protein or peptide (MIMPD), this encoding nucleic acid and uses of these substances |
| 02/12/2004 | DE10112515B4 Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität A method for detecting cytosine methylation patterns with high sensitivity |
| 02/12/2004 | CA2523011A1 Clubroot resistant brassica oleracea plants |
| 02/12/2004 | CA2505849A1 Novel tricistronic vectors and uses therefor |
| 02/12/2004 | CA2501415A1 Method of selecting cells for somatic cell nuclear transfer |
| 02/12/2004 | CA2495556A1 Methods and kits for synthesis of sirna expression cassettes |
| 02/12/2004 | CA2495478A1 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 02/12/2004 | CA2494868A1 Allele-specific sirna-mediated gene silencing |
| 02/12/2004 | CA2494859A1 Sirna-mediated gene silencing with viral vectors |
| 02/12/2004 | CA2494837A1 Novel druggable regions in set domain proteins and methods of using the same |
| 02/12/2004 | CA2494607A1 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 02/12/2004 | CA2494478A1 Fluorescence correlation spectroscopy instrument |
| 02/12/2004 | CA2494471A1 Protein containing a burp domain |
| 02/12/2004 | CA2494368A1 Seed-associated promoter sequences |
| 02/12/2004 | CA2494362A1 Apparatus and method for fabricating, sorting, and integrating materials with holographic optical traps |
| 02/12/2004 | CA2494311A1 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/12/2004 | CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof |
| 02/12/2004 | CA2494240A1 Maxs as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493993A1 Method of measuring molecular interactions |
| 02/12/2004 | CA2493752A1 Papsss as modifiers of the axin pathway and methods of use |
| 02/12/2004 | CA2493745A1 Method and device for protein delivery into cells |
| 02/12/2004 | CA2493364A1 Inversion of the negative-selective effect of negative marker proteins using selection methods |
| 02/12/2004 | CA2492966A1 Method for the expression of unknown environmental dna into adapted host cells |
| 02/12/2004 | CA2492945A1 Tocopherol biosynthesis related genes and uses thereof |
| 02/12/2004 | CA2492544A1 Modification of seed oil by the expression of a putative cytidyltransferase in transgenic plants |
| 02/11/2004 | EP1388588A1 Nucleic acid-separating method and nucleic acid-extracting reagent |
| 02/11/2004 | EP1388587A1 Biomolecular substrate and method and apparatus for examination and diagnosis using the same |
| 02/11/2004 | EP1388521A1 Method for preparing a nanowire crossbar structure and use of a structure prepared by this method |
| 02/11/2004 | EP1388283A1 Nonhuman model animal of oligodendrocyte development disability |
| 02/11/2004 | EP1387895A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 02/11/2004 | EP1387891A2 Compounds and methods for inhibiting axillary malodour |
| 02/11/2004 | EP1387890A2 Peptidylarginine deiminase 6 |
| 02/11/2004 | EP1387889A2 Kinases and phosphatases |
| 02/11/2004 | EP1387888A2 Nucleic acid-associated proteins |
| 02/11/2004 | EP1387886A2 Proteases |